Table 2.

Previous treatments

Characteristic	No	%
No. of previous treatment lines
2	9	19.2
3	19	40.4
4	19	40.4
Regorafenib before TAS-102
Yes	28	59.6
No	19	40.4
Response to first-line chemotherapy
CR	1	2.1
PR	15	31.9
SD	22	46.8
PD	9	19.2